Norepinephrine modulates the inflammatory and proliferative phases of wound healing.

BACKGROUND Injury results in the massive release of norepinephrine (NE) into the peripheral circulation. Recent investigations have demonstrated functional adrenoreceptors on the cellular mediators of cutaneous wound healing and NE-induced phenotypic alterations in immune cells have been demonstrated in vitro. Despite this, there is little description of how NE might alter the phases of wound healing in vivo. The purpose of this study was to compare cutaneous wound healing in norepinephrine-intact and norepinephrine-depleted mice. METHODS Norepinephrine-depleted (NED) mice were generated by chemical axotomy with 6-hydroxydopamine and compared with norepinephrine-intact (NEI) animals (n = 6-12 per group, per time point). Using an excisional wound model, neutrophil recruitment was measured by myeloperoxidase assay. Macrophage recruitment and angiogenesis were measured by immunohistochemistry and re-epithelialization was determined histologically. The development of incisional wound disruption strength was determined over time. Finally, macrophage scavenger function was assessed by an in vitro latex bead phagocytosis assay. RESULTS Wounds from NEI mice demonstrated greater neutrophil infiltration than NED wounds (24, 72 hours; p < 0.05). Wound macrophage recruitment was initially higher in NEI animals (24 hours, p < 0.05), but was eventually surpassed by that of NED animals (120 hours, p < 0.05). Angiogenesis was decreased while re-epithelialization was accelerated in NEI animals (p < 0.05). Wound disruption strength and macrophage scavenger function were unaltered between NED and NEI mice. CONCLUSIONS Norepinephrine modulates the inflammatory and proliferative phases of wound healing in a temporally defined, cell-specific manner. By increasing recruitment of innate immune cells and expediting wound closure, norepinephrine appears to play a protective role in defense against infection.

[1]  A. Desmoulière,et al.  Sympathetic denervation accelerates wound contraction but delays reepithelialization in rats , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[2]  M. Manns,et al.  β2‐Adrenoceptor‐mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics , 2005, European journal of immunology.

[3]  R. Gamelli,et al.  Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis , 2005, Journal of Neuroimmunology.

[4]  G. Tsujimoto,et al.  Gene deletion of dopamine β-hydroxylase and α1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling , 2004 .

[5]  D. Mukhopadhyay,et al.  Ablation of Peripheral Dopaminergic Nerves Stimulates Malignant Tumor Growth by Inducing Vascular Permeability Factor/Vascular Endothelial Growth Factor-Mediated Angiogenesis , 2004, Cancer Research.

[6]  R. Gamelli,et al.  Bone Marrow Norepinephrine Mediates Development of Functionally Different Macrophages After Thermal Injury and Sepsis , 2004, Annals of surgery.

[7]  S. Hsu,et al.  Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNF alpha-caspase signaling pathway. , 2004, Cardiovascular research.

[8]  M. De la Fuente,et al.  Noradrenaline and its end metabolite 3-methoxy-4-hydroxyphenylglycol inhibit lymphocyte chemotaxis: Role of alpha- and beta-adrenoreceptors , 2003, Molecular and Cellular Biochemistry.

[9]  M. De la Fuente,et al.  Regulation of phagocytic process of macrophages by noradrenaline and its end metabolite 4-hydroxy-3-metoxyphenyl-glycol. Role of α- and β- adrenoreceptors , 2003, Molecular and Cellular Biochemistry.

[10]  A. Sood,et al.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  R. Isseroff,et al.  PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. , 2003, The Journal of biological chemistry.

[12]  R. Gamelli,et al.  The effect of thrombocytopenia on dermal wound healing. , 2003, The Journal of investigative dermatology.

[13]  J. Ryan,et al.  Catecholamines in a macrophage cell line , 2003, Journal of Neuroimmunology.

[14]  G. Maestroni Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development , 2002, Journal of Neuroimmunology.

[15]  P. Rice,et al.  Chemical Sympathectomy Alters Numbers of Splenic and Peritoneal Leukocytes , 2002, Brain, Behavior, and Immunity.

[16]  L. DiPietro,et al.  Age-related alterations in the inflammatory response to dermal injury. , 2001, The Journal of investigative dermatology.

[17]  R. Gamelli,et al.  Norepinephrine Modulates Myelopoiesis After Experimental Thermal Injury With Sepsis , 2001, Annals of surgery.

[18]  G. Maestroni Dendritic Cell Migration Controlled by α1b-Adrenergic Receptors1 , 2000, The Journal of Immunology.

[19]  M. Franz,et al.  Use of the wound healing trajectory as an outcome determinant for acute wound healing , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[20]  J. Schölmerich,et al.  Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes , 2000, Journal of leukocyte biology.

[21]  H. Kleinman,et al.  Impaired wound repair and delayed angiogenesis in aged mice. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[22]  S. Oddera,et al.  beta 2-agonist-induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and Mac-1 expression or with impairment of polymorphonuclear leukocyte antibacterial activity. , 1999, Respiratory medicine.

[23]  V. Sanders,et al.  Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. , 1999, Journal of immunology.

[24]  E. Vizi,et al.  Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoceptor mediated mechanism , 1998 .

[25]  M. Zurowski,et al.  Sympathetic denervation impairs epidermal healing in cutaneous wounds , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[26]  J. Michel,et al.  Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. , 1998, Experimental cell research.

[27]  A. Barbul,et al.  General principles of wound healing. , 1997, The Surgical clinics of North America.

[28]  D. Kasprowicz,et al.  Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. , 1997, Journal of immunology.

[29]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[30]  C. Marfurt,et al.  Sympathetic stimulation of corneal epithelial proliferation in wounded and nonwounded rat eyes. , 1996, Investigative ophthalmology & visual science.

[31]  M. Schedlowski,et al.  Catecholamine-Induced Leukocytosis: Early Observations, Current Research, and Future Directions , 1996, Brain, Behavior, and Immunity.

[32]  B. Pomeranz,et al.  Surgical wound healing monitored repeatedly in vivo using electrical resistance of the epidermis. , 1996, Physiological measurement.

[33]  S. Felten,et al.  Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. , 1995, Journal of immunology.

[34]  M. A. Qureshi,et al.  Profile of chicken macrophage functions after exposure to catecholamines in vitro. , 1994, Immunopharmacology and immunotoxicology.

[35]  S. Kunkel,et al.  Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. , 1994, Journal of immunology.

[36]  G. Maestroni,et al.  Noradrenergic modulation of lymphohematopoiesis. , 1994, International journal of immunopharmacology.

[37]  D. Feliciano,et al.  The catecholamine response to multisystem trauma. , 1992, Archives of surgery.

[38]  R. Taylor,et al.  Monoamines alter in vitro migration of chicken leukocytes. , 1990, Developmental and comparative immunology.

[39]  D. Marcano,et al.  Hypothalamic and telencephalic catecholamine content in the brain of the teleost fish, Pygocentrus notatus, during the annual reproductive cycle. , 1990, General and comparative endocrinology.

[40]  S. Felten,et al.  Noradrenergic reinnervation of the rat spleen following chemical sympathectomy with 6-hydroxydopamine: Pattern and time course of reinnervation , 1990, Brain, Behavior, and Immunity.

[41]  A. Munson,et al.  Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. , 1988, Cellular immunology.

[42]  S. Albelda,et al.  Characterization of beta-adrenergic receptors in cultured human and bovine endothelial cells. , 1988, Journal of applied physiology.

[43]  R. Gamelli,et al.  Is impaired wound healing caused by infection or nutritional depletion? , 1987, Surgery.

[44]  R. Gamelli,et al.  Immunomodulators and wound healing. , 1987, The Journal of trauma.

[45]  R. Gamelli,et al.  Inhibition of wound healing by Corynebacterium parvum , 1986 .

[46]  E. Deitch,et al.  Stress hormones modulate neutrophil and lymphocyte activity in vitro. , 1986, The Journal of trauma.

[47]  C. Abrass,et al.  Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. , 1985, Journal of immunology.

[48]  S. Sasagawa,et al.  Assay method for myeloperoxidase in human polymorphonuclear leukocytes. , 1983, Analytical biochemistry.

[49]  E. Pfendt,et al.  Characterization of α- and β-Adrenergic Agonist Stimulation of Adenylate Cyclase Activity in Human Epidermal Keratinocytes In Vitro , 1983 .

[50]  A. Alho,et al.  Plasma catecholamines in severely injured patients: A prospective study on 45 patients with multiple injuries , 1975, The British journal of surgery.

[51]  R. Pitman,et al.  Transmitter substances in insects: a review. , 1971, Comparative and general pharmacology.

[52]  T. A. Smith THE OCCURRENCE, METABOLISM AND FUNCTIONS OF AMINES IN PLANTS , 1971, Biological reviews of the Cambridge Philosophical Society.

[53]  J. Champlain Degeneration and Regrowth of Adrenergic Nerve Fibers in the Rat Peripheral Tissues after 6-Hydroxydopamine , 1971 .

[54]  G. Kidder,et al.  The biosynthesis of catecholamines in two genera of protozoa. , 1966, The Journal of biological chemistry.

[55]  J. Fine,et al.  Protection of Functional and Vascular Integrity of the Spleen in Traumatic Shock by Denervation.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[56]  T. Dougherty,et al.  The quantitative and qualitative responses of blood lymphocytes to stress stimuli. , 1953, The Journal of laboratory and clinical medicine.

[57]  H. Thoenen,et al.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine , 2004, Naunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie.

[58]  S. Hsu,et al.  Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways. , 2004, Cardiovascular research.

[59]  M. Franz,et al.  Abdominal wall repair is delayed during hepatic regeneration. , 2001, The Journal of surgical research.

[60]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[61]  J. Folkman,et al.  Angiogenesis and angiogenesis inhibition: an overview. , 1997, EXS.

[62]  Y. Abiko,et al.  Role of the sympathetic nervous system in the ischemic and reperfused heart. , 1996, EXS.

[63]  D. J. Donaldson,et al.  Influence of catecholamines on epidermal cell migration during wound closure in adult newts. , 1984, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[64]  H. Thoenen,et al.  The pharmacology of 6-hydroxydopamine. , 1973, Annual Review of Pharmacology.